Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: HOG QL12-153 Principal Investigator: Picus, Joel
Title: Phase II study of Fosaprepitant + 5HT3 receptor antagonists + Dexamethasone in patients with germ cell tumors undergoing 5 day Cisplatin based chemotherapy
Phase: II Disease Site: Other Urinary
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to determine if EMEND can reduce sudden and delayed symptoms of nausea and vomiting in patients with germ cell cancer that are receiving standard
treatment with a 5-day Cisplatin-based chemotherapy.
 
More Information:
clinicaltrials.gov
Internal Protocol Documents (requires Siteman administrative database password)